ReviewFrontiers in endocrinology2026
Chronobiology of fracture repair: local molecular clocks, rhythm protection, and time-anchored translation.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fracture repair is a prototypic regenerative process in adult tissues and proceeds through a temporally organised sequence of haematoma formation and inflammation, cartilaginous callus formation, hard callus mineralisation, and callus remodelling. Conventional fracture research has primarily attributed variation in healing outcomes to mechanical stability, vascular supply, inflammation, metabolic bone status, drug exposure, nutrition, and rehabilitation loading. Time, by contrast, has often been treated as a background variable. Emerging evidence from circadian biology and molecular-clock research indicates that bone turnover markers, endocrine signals, immune responses, vascular function, sleep-wake organisation, and the activities of osteoblasts, osteoclasts, chondrocytes, macrophages, and endothelial cells are subject to rhythmic regulation. In particular, Per2::Luc oscillation at the mouse femur fracture site and its responsiveness to parathyroid hormone (PTH) provide direct preclinical evidence that a local molecular clock can operate within the fracture repair niche. Fracture chronobiology, however, remains at an early translational stage. Current evidence is derived largely from animal models, cell studies, human bone-marker physiology, sleep and circadian-disruption experiments, and perioperative literature. Direct time-resolved clinical data in human fracture repair remain sparse. Accordingly, the available evidence does not justify recommending a specific clock time for surgery, drug administration, blood sampling, loading, or rehabilitation to improve fracture healing. We argue that the immediate translational value of fracture chronobiology lies not in premature clinical chronotherapy but in moving fracture research and perioperative care from a time-agnostic to a time-anchored framework. The perioperative period should be regarded as a rhythm-vulnerable window in which avoidable disruption from trauma, pain, anaesthesia, nocturnal light, sleep fragmentation, and medication exposure may be reduced. At the same time, fracture studies should systematically record the timing of injury, admission, anaesthesia, surgery, drug administration, biological sampling, sleep, light exposure, activity, rehabilitation, and imaging follow-up. A time-anchored research framework can clarify whether rhythmic variables influence callus formation, mineralisation, remodelling, nonunion, and functional recovery, thereby providing a measurable foundation for future fracture chronobiology trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.